/Companies

Avammune Therapeutics

6 known investors

Find your way into Avammune Therapeutics

Sign up to see every warm intro you have to Avammune Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Avammune Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.

Founders & leadership

A
ArunFounder | CEO
A
AdityaFounder | CSO
S
SrinivasanFounder | Director

Investors · 6

Frequently asked questions

What does Avammune Therapeutics do?
Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.
Who founded Avammune Therapeutics?
Avammune Therapeutics was founded by Arun, Aditya, Srinivasan.
Who are Avammune Therapeutics's investors?
Avammune Therapeutics's investors include 1Crowd, Capital2B, Redstart Labs, Shastra VC, IvyCap Ventures, The Chennai Angels.